Lisinopril EP Impurity E - Request Quote
Lisinopril EP Impurity E
| SZ CAT No: | SZ-L027006 |
| CAS No | NA |
| Mol.F. | C21H31N3O5 : H2O |
| Mol.Wt. | 405.5 : 18.0 |
| Inv. Status | In Stock |
| Rel. CAS No | 85955-59-5 (free base) |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lisinopril EP Impurity E is chemically (2S)-1-[(2S)-6-Amino-2-[[(1R)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid hydrate (as per EP). It is also known as Lisinopril R,S,S-isomer (EP). Lisinopril EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Lisinopril EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lisinopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lisinopril EP Impurity E
Purchase Lisinopril EP Impurity E
Lisinopril EP Impurity E suppliers
Lisinopril EP Impurity E manufacturers
Lisinopril EP Impurity E price
Order Lisinopril EP Impurity E
Enquire Lisinopril EP Impurity E
Lisinopril EP Impurity E cost
Lisinopril EP Impurity E Supplier
Lisinopril EP Impurity E Distributor
Lisinopril EP Impurity E for Method Validation
Lisinopril Reference Standard
Lisinopril EP Impurity E for ANDA Filing
Lisinopril EP Impurity E for Forced Degradation Studies
Lisinopril EP Impurity E Identification Standards
Lisinopril EP Impurity E for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.